| Joseph A Alcina, CRNA | |
|
3510 N Causeway Blvd, 404, Metairie, LA 70002-3531 | |
| (504) 779-5515 | |
| (504) 779-5568 |
| Full Name | Joseph A Alcina |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 3510 N Causeway Blvd, Metairie, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063851202 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN109859 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Jefferson Medical Center | Marrero, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Childrens Hospital Anesthesia Corporation | 0446152862 | 221 |
News Archive
When an average slice of pumpkin pie and scoop of vanilla ice cream can contain 46 grams of sugar – nearly twice the recommended daily added sugar intake of 25 grams for women and well above the recommendation of 36 grams for men– the holidays can be hazardous for anyone watching their waistlines.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
The three most prominent current or former governors running for president -; Rick Perry, Mitt Romney and Jon M. Huntsman Jr. -; are firmly united in their commitment to repealing President Obama's health care law. But that unanimity masks a broad divergence in their approaches to the issue while in office, spanning the spectrum of Republican positioning.
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
An exciting new research project is being launched by York Teaching Hospital NHS Foundation Trust to track the health and wellbeing of children and adults.
› Verified 2 days ago
| Entity Name | Childrens Hospital Anesthesia Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649362740 PECOS PAC ID: 0446152862 Enrollment ID: O20040124000258 |
News Archive
When an average slice of pumpkin pie and scoop of vanilla ice cream can contain 46 grams of sugar – nearly twice the recommended daily added sugar intake of 25 grams for women and well above the recommendation of 36 grams for men– the holidays can be hazardous for anyone watching their waistlines.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
The three most prominent current or former governors running for president -; Rick Perry, Mitt Romney and Jon M. Huntsman Jr. -; are firmly united in their commitment to repealing President Obama's health care law. But that unanimity masks a broad divergence in their approaches to the issue while in office, spanning the spectrum of Republican positioning.
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
An exciting new research project is being launched by York Teaching Hospital NHS Foundation Trust to track the health and wellbeing of children and adults.
› Verified 2 days ago
| Entity Name | Parish Anesthesia Of Jefferson, L.l.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508054560 PECOS PAC ID: 6608965975 Enrollment ID: O20071210000390 |
News Archive
When an average slice of pumpkin pie and scoop of vanilla ice cream can contain 46 grams of sugar – nearly twice the recommended daily added sugar intake of 25 grams for women and well above the recommendation of 36 grams for men– the holidays can be hazardous for anyone watching their waistlines.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
The three most prominent current or former governors running for president -; Rick Perry, Mitt Romney and Jon M. Huntsman Jr. -; are firmly united in their commitment to repealing President Obama's health care law. But that unanimity masks a broad divergence in their approaches to the issue while in office, spanning the spectrum of Republican positioning.
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
An exciting new research project is being launched by York Teaching Hospital NHS Foundation Trust to track the health and wellbeing of children and adults.
› Verified 2 days ago
| Entity Name | Aec Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346574217 PECOS PAC ID: 6305983214 Enrollment ID: O20091027000035 |
News Archive
When an average slice of pumpkin pie and scoop of vanilla ice cream can contain 46 grams of sugar – nearly twice the recommended daily added sugar intake of 25 grams for women and well above the recommendation of 36 grams for men– the holidays can be hazardous for anyone watching their waistlines.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
The three most prominent current or former governors running for president -; Rick Perry, Mitt Romney and Jon M. Huntsman Jr. -; are firmly united in their commitment to repealing President Obama's health care law. But that unanimity masks a broad divergence in their approaches to the issue while in office, spanning the spectrum of Republican positioning.
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
An exciting new research project is being launched by York Teaching Hospital NHS Foundation Trust to track the health and wellbeing of children and adults.
› Verified 2 days ago
| Entity Name | Zephyr Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891087458 PECOS PAC ID: 1658559125 Enrollment ID: O20110705000180 |
News Archive
When an average slice of pumpkin pie and scoop of vanilla ice cream can contain 46 grams of sugar – nearly twice the recommended daily added sugar intake of 25 grams for women and well above the recommendation of 36 grams for men– the holidays can be hazardous for anyone watching their waistlines.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
The three most prominent current or former governors running for president -; Rick Perry, Mitt Romney and Jon M. Huntsman Jr. -; are firmly united in their commitment to repealing President Obama's health care law. But that unanimity masks a broad divergence in their approaches to the issue while in office, spanning the spectrum of Republican positioning.
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
An exciting new research project is being launched by York Teaching Hospital NHS Foundation Trust to track the health and wellbeing of children and adults.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph A Alcina, CRNA 255 W Michigan Ave, Po Box 1123, Jackson, MI 49201-2218 Ph: (517) 787-6440 | Joseph A Alcina, CRNA 3510 N Causeway Blvd, 404, Metairie, LA 70002-3531 Ph: (504) 779-5515 |
News Archive
When an average slice of pumpkin pie and scoop of vanilla ice cream can contain 46 grams of sugar – nearly twice the recommended daily added sugar intake of 25 grams for women and well above the recommendation of 36 grams for men– the holidays can be hazardous for anyone watching their waistlines.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
The three most prominent current or former governors running for president -; Rick Perry, Mitt Romney and Jon M. Huntsman Jr. -; are firmly united in their commitment to repealing President Obama's health care law. But that unanimity masks a broad divergence in their approaches to the issue while in office, spanning the spectrum of Republican positioning.
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
An exciting new research project is being launched by York Teaching Hospital NHS Foundation Trust to track the health and wellbeing of children and adults.
› Verified 2 days ago
Kristi F Simon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3510 N Causeway Blvd, Suite 404, Metairie, LA 70002 Phone: 504-779-5515 | |
Brian F. Brown, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3510 N Causeway Blvd, Suite 404, Metairie, LA 70002 Phone: 504-779-5515 Fax: 504-779-5568 | |
Dominick Diecidue, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3510 N Causeway Blvd, Suite 404, Metairie, LA 70002 Phone: 504-779-5515 Fax: 504-779-5568 | |
Brandon C. Brown, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3510 N Causeway Blvd, Suite 404, Metairie, LA 70002 Phone: 504-779-5515 Fax: 504-779-5568 | |
Joellyn Mary Grass, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3510 N Causeway Blvd, Metairie, LA 70002 Phone: 504-779-5515 | |
Steve Gonzales, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3510 N Causeway Blvd, Metairie, LA 70002 Phone: 504-779-5568 | |
Ronald E. Bankert, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3510 N Causeway Blvd, Suite 404, Metairie, LA 70002 Phone: 504-779-5515 |